Myasthenia gravis in pregnancy and birth: Identifying risk factors, optimising care

European Journal of Neurology

Volumn 14, Issue 1, 2007, Pages 38-43

  Hoff, J M ^a,d   Daltveit, A K ^b,c   Gilhus, N E ^a,d  

^a Department of Clinical Medicine ^*  (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c Medical Birth Registry of Norway   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Delivery; Myasthenia gravis; Neonatal myasthenia gravis; Pregnancy; Thymectomy

Indexed keywords

ARTICLE; BIRTH; CONTROLLED STUDY; DATA ANALYSIS; ELECTIVE SURGERY; FEMALE; FETUS DISTRESS; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; MOTHER; MYASTHENIA GRAVIS; NORWAY; PREGNANCY; PRIORITY JOURNAL; REGISTRATION; RISK ASSESSMENT; RISK FACTOR; THYMECTOMY;

FEMALE; HUMANS; INFANT, NEWBORN; MALE; MYASTHENIA GRAVIS; MYASTHENIA GRAVIS, NEONATAL; PARTURITION; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; REGISTRIES; RISK FACTORS; THYMECTOMY;

EID: 33846170891     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2006.01538.x     Document Type: Article

References (22)

1. Vincent A, Rothwell P. Myasthenia gravis. Autoimmunity 2004; 37: 317-319.
2. Batocchi AP, Majolini L, Evoli A, Lino MM, Minisci C, Tonali P. Course and treatment of myasthenia gravis during pregnancy. Neurology 1999; 52: 447-452.
3. Vincent A, Palace J, Hilton-Jones D. Myasthenia gravis. Lancet 2001; 357: 2122-2128.
4. Batocchi AP. Pregnancy and myasthenia gravis. In: Vincent A, Martino G, eds. Autoantibodies in Neurological Diseases. Milan: Springer-Verlag Italia, 2002: 28-39.
5. Hoff JM, Daltveit AK, Gilhus NE. Myasthenia gravis - consequences for pregnancy, delivery and the newborn. Neurology 2003; 61: 1362-1366.
6. Hoff JM, Daltveit AK, Gilhus NE. Asymptomatic myasthenia gravis influences pregnancy and birth. European Journal of Neurology 2004; 11: 559-562.
7. Papazian O. Transient neonatal myasthenia gravis. Journal of Child Neurology 1992; 7: 135-141.
8. Vincent A, Newland C, Brueton L, et al. Arthrogryposis multiplex congenita with maternal autoantibodies specific for a fetal antigen. Lancet 1995; 346: 24-25.
9. Brueton LA, Huson SM, Cox PM, et al. Asymptomatic maternal myasthenia as a cause of the Pena-Shokeir phenotype. American Journal of Medical Genetics 2000; 92: 1-6.
10. Skomsvoll JF, Østensen M, Baste V, Irgens LM. Validity of a rheumatic disease diagnosis in the Medical Birth Registry of Norway. Acta Obstetricia et Gynecologica Scandinavica 2002; 81: 831-834.
11. Djelmis J, Sostarko M, Mayer D, Ivanisevic M. Myasthenia gravis in pregnancy: report on 69 cases. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2002; 104: 21-25.
12. Andersen AMN, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal age and fetal loss: population based register linkage study. BMJ 2000; 320: 1708-1712.
13. Adamson SJ, Alessandri LM, Badawi N, Burton PR, Pemberton P, Stanley F. Predictors of neonatal encephalopathy in full term infants. BMJ 1995; 311: 598-602.
14. Ciafaloni E, Massey JM. The management of myasthenia gravis in pregnancy. Seminars in Neurology 2004; 1: 95-100.
15. Romi F, Gilhus NE, Aarli JA. Myasthenia gravis: clinical, immunological, and therapeutic advances. Acta Neurologica Scandinavica 2005; 111: 134-141.
16. Vincent A, Leite MI. Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis. Current Opinion in Neurology 2005; 18: 519-525.
17. Park-Wyllie L, Mazzotta P, Pastuszak A, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000; 62: 385-392.
18. Lamah M, Scott HJ. Inflammatory bowel disease and pregnancy. International Journal of Colorectal Disease 2002; 17: 216-222.
19. Briggs GG, Freeman RK, Sumner JY. Drugs in Pregnancy and Lactation. A Reference Guide to Fetal and Neonatal Risk, 6th edn. Philadelphia: Lippincott-Williams & Wilkins, 2002.
20. Ferrero S, Pretta S, Nicoletti A, Petrera P, Ragni N. Myasthenia gravis: management issues during pregnancy. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2005; 121: 129-138.
21. Eisenkraft JB, Brook WJ, Papatestas AE. Sensitivity to vecoronium in myasthenia gravis: a dose response study. Canadian Journal of Anaesthesia 1990; 37: 301-306.
22. Dunsire MF, Clarke SG, Stedmon JJ. Undiagnosed myasthenia gravis unmasked by neuromuscular blockade. British Journal of Anaesthesia 2001; 86: 727-730.